ClinicalTrials.gg
Sign In
Drug

Florbetapir clinical trials

Also written Amyvid and 18F-AV-45.

studies test it
35
open now
1
in phase 3
6
first study started
2007

How each study uses florbetapir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the florbetapir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
14 Jan 2013 · Amyvid · EMEA/H/C/002422 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

florbetapir F 18
25
florbetapir
19
Florbetapir (18F)
6

Brand

Amyvid
29

Development codes

18F-AV-45
26

Studies by the year they started

35 studies that test it; most in 2012 (6)

Studies that test florbetapir, by start year
YearStudies
20072
20084
20095
20103
20114
20126
20132
20145
20171
20191
20211
20241

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
7
Phase 2
10
Phase 3
6
Phase 4
7
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Alzheimer Disease
26
Postoperative Cognitive Complications
1
Dementia
1
Multiple Sclerosis
1
Parkinson Disease
1
Glioblastoma
1

Who runs them

Industry 27 · Other 8

Avid Radiopharmaceuticals (27) · University of California, San Francisco (1) · Centre Hospitalier Universitaire, Amiens (1) · University Hospital, Tours (1) · Invicro (1) · Institute for Neurodegenerative Disorders (1) · Universidad Central del Caribe (1) · The Cleveland Clinic (1)

Often tested with

Tested in the same studies.

Flortaucipir (1) · Pittsburgh compound B (1) · Fluorodeoxyglucose F18 (1) · Florbenazine F 18 (1) · Florzolotau F-18 (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses florbetapir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 35

See all 35 studies that test florbetapir →

Given beside what is tested · 6 — florbetapir is usual care or a partner of the new treatment

Codes

What other systems call florbetapir · ClinicalTrials.gg INT005524

  • MeSH (NLM) C545186florbetapirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6867Q6IKODFLORBETAPIRConfirmed NLM, Wikidata
  • RxNorm 1427225Confirmed FDA, Wikidata
  • Wikidata Q27264221florbetapirConfirmed NLM, Wikidata

Also registered as florbetapir f-18 (UNII 6W15Z5R0RU · RxNorm 1427224).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.